500+
Biologics works with over 500 contracted payer networks.
Business Overview
Biologics by McKesson
Simplifying access to therapies for patients with cancer and rare diseases.
Delivering Personalized Specialty Pharmacy Care
Personalized patient care has long been regarded as fundamental to quality healthcare. Tailoring treatment to the individual not only boosts the morale of patients confronting difficult diagnoses, but also significantly enhances health outcomes.
As one of the largest distributors of oncology and specialty medicines, McKesson provides integrated services across the drug lifecycle and ensures therapies make their way to those who are counting on them. Biologics by McKesson (Biologics) is a specialty pharmacy providing services that simplify access to therapies and deliver personalized care. With more than 30 years of specialty pharmacy experience, Biologics is a trusted leader in complex care. We help patients access and stay on oncology, rare disease and cell and gene therapies through personalized support, deep clinical expertise and coordinated care services.
Biologics by McKesson at a Glance
A proven specialty pharmacy, delivering expertise to complex medication journeys.
$100M
Biologics has identified $100 million in financial assistance opportunities for patients.²
95%
Over 95% of Biologics dispenses had an out-of-pocket payment of $50 or less. ²
30K
We maintain 30,000+ active provider relationships³
200+
We offer more than 200 oncology and rare disease therapies.
145+
We have access to 145+ limited distribution therapies.
Our Focus Areas
As a leading specialty pharmacy provider, Biologics specializes in cancer and rare disease areas with the goal of simplifying access to therapies and delivering personalized care to help patients understand how to take their medication, manage side effects and achieve the best possible outcomes. Our capabilities include:
Oncology
Rare and orphan diseases
Cell and gene therapies
Multidisciplinary care
Medication and side effect management
Identifying financial resources
Prior authorization for insurance coverage
Accelerating Care Through Our Oncology Ecosystem
By connecting data-driven insights with deep therapeutic expertise, we help biopharma and community providers navigate complexity and bring state-of-the-art care closer to home.
Explore Biologics by McKesson Stories and Insights
McKesson Accelerate 2026 Centers What Practices Need Most
Connected Support in Rare Disease Care
Enabling Simpler Cell and Gene Therapy Delivery
Preventing Medication Waste
30 Years of Patient Empowerment: Biologics’ Journey
Beyond the Counter: The Many Faces of Pharmacy
Learn More About McKesson’s Solutions
Oncology & Multispecialty Solutions
We walk alongside our patients, providing specialty drugs for diseases that are complex and require extra care. We also help patients understand how to thrive with these specialty medications.
Biopharma Capabilities
We help our biopharma partners develop innovative, customized solutions and therapy-specific launch strategies to deliver exceptional results.
¹ Based on cumulative Biologics by McKesson dispense data from 2011–2025.
² Based on Biologics by McKesson data for calendar year 2025.
³ Based on current Biologics by McKesson provider relationship data.